Has Frank Simone, MD received payments from drug or device companies?

Yes. Drug and device makers reported $95,539 in general payments to Frank Simone, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Simone, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Simone, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Simone, MD

Diagnostic Radiology · Indiana, PANPI 1932159084

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $95,490 of the $95,539 with a category attached, or 99.9%. Pfizer accounts for 99.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $49,761 and has fallen 91.9% since, to $4,045 in 2025. Among diagnostic radiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$95,539in general payments, 2019–2025

Across 32 payments — averaging $2985.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$95K
Abiomed$26
Bayer$22

$6,480in research payments, 2019–2025

Across 1 payment — averaging $6480.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$6K

What the payments were for

Consulting fees$95,490100%
Food & beverage$490%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	30	$95,490
Abiomed	1	$26
Bayer	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ELREXFIO$95,490

How this compares

$95,539 in reported general payments places this provider in the 95th percentile of 1,665 diagnostic radiology providers in Pennsylvania.

See all diagnostic radiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$4,807

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Indiana

Rajan AgarwalAbington$2.1M
William CorseDoylestown$1.3M
Joan ProwdaPhiladelphia$1.1M
Jill LangerPhiladelphia$895K
Lisa JonesPhiladelphia$895K
Philip LimDanville$879K
Evan SiegelmanPhiladelphia$704K
Robert ShortPittsburgh$669K
Patrick OkanePhiladelphia$453K
Parvati RamchandaniPhiladelphia$411K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →